*SUBJECT TO CHANGE
All session times are listed in Eastern Time (ET).
To view the PDF version of the Scientific Programme, please click here.
0800-1200
10th Symposium on Affordable New Technologies in Urology (SANTU) and 5th Best Affordable New Technologies in Urology Contest (BANTUC)
Opening SANTU
SANTU Lectures
Relevant ePosters/videos
What can endourology offer in Sub-Saharan Africa?
Relevant ePosters/videos
The case for endourology in resource restricted environment: Cameroun
The art of simplicity and affordable technology
Relevant ePosters/videos
Low Cost Innovations which have reached the masses and the Markets: A Critical Appraisal
KISS (Keep It Simple, Stupid) and IP (Idiot Proof) principles when developing frugal devices
Relevant ePosters/videos
Changes in how we approached volunteerism during the pandemic: seeing how we can use these ideas moving forward
Low Cost Urology
The “Innovators Talk Show”: Dialogues with the innovators How did the Innovators make sure that their idea saw the light of the day? This would be an idea to map the brain of the innovators. We would question the doyens of urological innovations and try to study how they think, act or follow up on the idea to the next level. During this session which will be a Tee- a-Tee with the innovators we would like to give take home messages to the budding innovators Innovators Panel on the show: Sanjay Kulkarni Daniel Yachia Ashish Patil Mohammed Lezrek
5th Best Affordable New Technologies in Urology contest (BANTUC)
Presentation of 5th Best Affordable New Technologies in Urology contest (BANTUC)
Presentation of the projects by the finalist list
Announcement of the Results and Awards Distribution of 5th Best Affordable New Technologies in Urology contest (BANTUC)
Award distributions for the Best Moderated Poster, Best Un-moderated Poster and Best Video presentations. and Closing SANTU-10 and Invitation to SANTU-11, 2023
Invitation to 6th Best Affordable New Technologies in Urology Contest (BANTUC)
0800-1000
Arab Urology Around the World (AAU) Symposium
SIU Welcome Remarks
AAU Welcome Remarks
Debate: What is The Best Option for 1.5 - 3 cm Renal Stone?
Option 1: Ambulatory Tubeless Mini-Percutaneous Nephrolithotomy
Option 2: Retrograde Intrarenal Surgery in the Management of Nephrolithiasis
Sacral Neuromodulation: Advancements in an Under- Utilized Therapy
Bladder and Bowel Dysfunction in Children
Novel Testosterone Replacement Therapy Options
Updates on Restorative Therapy for Erectile Dysfunction
Update in Treatment of Metastatic Prostate Cancer
The Use of 3D virtual Reality Models in Complex Renal Surgery
Laparoscopic Repair of Female Genitourinary fistulae: 10 years single center experience
Closing Remarks
0800-1200
Joint Colegio Mexicano de Urología (CMU) & Sociedad Mexicana de Urologia (SMU) Symposium (in Spanish/En español)
Bienvenida
Plática 1: ¿Biopsia Transperineal Nuevo Estándar Diagnóstico?
Plática 2: Situaciones en prostatectomia radical por mínima invasión
Platica 3: Prostatectomía radical de rescate ¿laparoscópica o abierta?
Plática 4: Terapia focal de rescate en Cáncer de Próstata
Platica 5: Seguridad del manejo con testosterona en el paciente con cáncer de próstata.
Platica 6: Manejo de la incontinencia urinaria post prostatectomía radical
Platica 7: Manejo de las estenosis de uretra post prostatectomía radical
Platica 8: Terapia en el paciente con cáncer de próstata hormono resistente
Receso
Plática 9: MIST vs HoLEP
Plática 10: Complicaciones en cirugía de hiperplasia prostática
Platica 11: MiniEcirs
Platica 12: Procedimientos Endourológicos bilaterales para cálculos renales
Plática 13: Abordajes complejos en ureterorrenoscopía
Plática 14: Reparación de fístulas vésico-vaginales por laparoscopia
Despedida
0800-1700
World Urological Oncology Federation (WUOF) Symposium
Meet and Greet International Colleagues
Framing of Theme
SESSION ONE | ADVANCED PROSTATE CANCER ALL TALKS 12 MINUTES FOLLOWED BY 3 MINUTE Q & A
Optimizing Treatment for Locally Advanced Prostate Cancer
Molecular Imaging – Beyond Detection
Bone Health 2022: mCSPC & mCRPC: Choice Agents, Timing and Duration, Monitoring |
Synchronous Chemotherapy and ARAT - The New Standard?
Molecular Medicine in CRPC Including DNA Repair Pathway
PSMA Theranostics: Current and Future Directions
Discussion
Break
SESSION TWO | BLADDER CANCER
Novel Intravesical Therapies for BCG-Unresponsive NMIBC
Novel Immunotherapies for NMIBC
Current Approach to High Grade T1 TC
Discussion
Robotic vs Open Cystectomy: Is There a Clear Winner?
The Future Landscape of Adjuvant and Neoadjuvant Therapy in Muscle-Invasive Bladder Cancer
T0 After Neoadjuvant Chemo—Are We Ready to Forego Local Therapy?
Trimodality Bladder Sparing for MIBC
Discussion
30 MINUTE WORKING LUNCH
SESSION THREE | SPECIAL GUEST LECTURE
Introduction
Novel Therapeutic Developments in Targeting the AR Pathway
Discussion
SESSION FOUR | KIDNEY
Molecular Biomarkers in RCC and Personalized Therapy
Is There a Role for Adjuvant Therapy in High Risk Localized Disease
Which Drug for Which Patient in Metastatic RCC
Small Renal Masses – Which Focal Therapy for Which Patient in 2022? Does it Matter?
Discussion
SESSION FIVE | PCA LOCALIZED PART 1
Lecture to be confirmed
PSMA PET and MRI - The New Diagnostic Algorithm?
New Modalities in Focal Therapy
Patient Selection, Targeting, and Follow-up in Focal Treatment
Novel Liquid Biomarkers in Prostate Cancer
Update on Tissue Based Prostate Biomarkers
Discussion
SESSION SIX | PCA LOCALIZED PART 2
High-Resolution Ultrasound for Prostate Cancer Diagnosis: A RCT and Review of Current Evidence
How Should We Do Biopsies in 2022
Optimizing Pre and Post operative Care with RP?
Role and Extent of Pelvic Lymph Node Dissection in the PSMA Era
Debunked Myths about Prostate Cancer
Discussion
Adjourn
1000-1200
Joint SIU - SAARC Association of Urological Surgeons (SAUS)
Learning Objectives: At the end of the session, the participants will be able to:
1000-1200
International Society for Sexual Medicine (ISSM) Symposium
Faculty Panel: Drs. John Mulhall, Melissa Kaufman, Faysal Yafi and Wayne Hellstrom.
Welcome
Case Study 1 – Prosthetics- role of antibiotics, length optimization, reservoir location
Discussion/Q&A (including literature recommendations)
Case Study 2 – Consent Issues, partner involvement, status post-priapism, failed device, infection
Discussion/Q&A (including literature recommendations)
Case Study 3 – Priapism, management, strategies for implants, timing, device choice, approach
Discussion/Q&A (including literature recommendations)
Cast study 4 – Intraoperative Complications- vascular injury, urethral injury, cross-over, perforation prox/distal, revision-loss of original reservoir
Discussion/Q&A (including literature recommendations)
Conclusions
1250-1700
Joint SIU-Chinese Urological Association (CUA) Symposium
Each Lecture is 10 minutes followed by 5 mins Q&A
Welcome
Section One: Renal Cancer
Renal Biopsies: Why and How?
To Screen or Not to Screen. That is the Question!
To Treat or Not to Treat a Small Renal Mass
To Clamp or Not to Clamp for Partial Nephrectomy: In Whom and How?
Section Two: Bladder Cancer
En-bloc Resection is the New Gold Standard?
Robotic Surgery for Bladder Cancer – Any Real Benefits?
Lymphnode Dissection in BCa – When and How?
Bladder Substitution Long Term Experience
Section Three: Urinary Stones
Metabolic Evaluation of Urinary Stones – Why Should We Do It?
Single Use Versus Re-Use Ureteroscopy: When and Why?
SWL for Urinary Stones: Past, Present, and Future
Lessons Learned from Small, Smaller, Smallest PCNL for Renal Stones.
Section Four: BPH
How to Treat a Prostate > 80 cc Best Surgically
Ejaculation Preserving Treatment for BPH: Sense or Nonsense
Handling and Prevention of Urinary Incontinence following BPH Surgery
How to Best Treat the Old and Fragile Patient with Moderate-Severe Male LUTS?
1300-1700
Indian Urology Around the World (USI)
1300-1500
Joint Kenya Association of Urological Surgeons (KAUS) and South African Urological Association (SAUA) Symposium
Learning Objectives: At the end of this session the attendees will:
Welcome Message
Policies and principles; A perspective on healthy industry engagement
Treatment of Urethral Strictures in Covid-19 Era - Urethral Dilatation vs Urethroplasty
Urethroplasty in Obliterative Urethral Stricture Disease - Transection vs Augmentation
Utility of Machine Learning in Predicting Complications of Urethroplasty
Current Status of Endourology in Kenya
BCG Therapy for High-Risk Bladder Cancers - Review of Local Challenges
Pragmatic Management of Prostate Cancer in Developing Countries
Take Home Messages
1500-1700
Pan-African Urological Surgeons Association (PAUSA) Symposium
Part 1 : African Urology 15:00 – 16:00 Chair : Pr Alexander Nwofor Co-Chair : Pr Papa Ahmed Fall Part 2 : Capacity Building in Urology in SSA 16:00 – 17:00 Chair : Pr Serigne Gueye Co-Chair : Pr Oluwabunmi Olaopa-Olopade
Landscape of Somatic Structural Variants in African Men with Advanced Prostate Cancer
Epidemiological and histopathological aspects of prostate cancer in three reference hospitals in Cameroon
Laparoscopy in Urology: Perspectives in Africa
Obstetrical Fistula in Sub Saharan Africa: Analysis of health system factors, and socio-economic impacts
Outcome of Excision and Primary "Anastomoses in the Management of Short Anterior Urethral Strictures in the Yaoundé Central Hospital
Discussion
Training in Minimally Invasive Urology in SSA : A Call for Action
Boosting Specialist Health Work Force in Africa.
Digital Health in Urology: Opportunities and Challenges in Africa
Discussion
1700-1800
Opening Ceremony
1815-1945
Exhibit Hall - Welcome Reception
1030-1700
Exhibit Hall
1030-1700
Exhibit Hall
1315-1515
Conference Highlights
Welcome and Introductions
Day One Hightlights
Day Two Highlights
Day Three Highlights
Day Four Highlights
Day Five Highlights
Closing Remarks
Wednesday, November 09
Please click on the session titles to view the session details when available.
Co-Chair: Arvind Ganpule, India
Honorary Chair: Daniel Yachia, Israel
0815-0820
0820-0830
0830-0840
0840-0850
0850-0900
0900-0910
0910-0920
0920-0930
0930-0940
0940-0950
0950-1000
1000-1010
1010-1050
1050-1055
1055-1145
1145-1150
1150-1155
1155-1200
Moderators: Saad Aldousari, Kuwait / Murilo Luz, Brazil
0800-0801
0801-0802
0802-0815
0815-0828
0828-0841
0841-0854
0854-0907
0907-0920
0920-0933
0933-0946
0946-0959
0959-1000
0800-0810
Héctor Raúl Vargas Zamora, Mexico
0810-0825
0825-0840
0840-0855
0855-0910
0910-0925
0925-0940
0940-0955
0955-1010
1010-1025
1025-1040
1040-1055
1055-1110
1110-1125
1125-1140
1140-1155
1155-1200
Héctor Raúl Vargas Zamora, Mexico
0730-0755
0755-0800
Laurence Klotz, Canada
Christopher Evans, United States
Peter Hammerer, Germany
0815-0830
0830-0845
0845-0900
0900-0915
0915-0930
0930-0945
0945-0955
0955-1010
Leonardo O. Reis, Brazil
Amlesh Seth, India
1015-1045
1030-1045
1045-1100
1100-1110
1110-1125
1125-1140
1140-1155
1155-1210
1210-1220
1220-1250
1250-1320
1310-1320
Simon Tanguay, Canada
Li-Ping Xie, People's Republic of China
1325-1340
1340-1355
1355-1410
1410-1425
1425-1435
1440-1455
1455-1510
1510-1525
1525-1540
1540-1555
1555-1610
1610-1620
1620-1750
1625-1640
1640-1655
1655-1710
1710-1725
1725-1740
1740-1750
1750-1755
1000-1005
1005-1020
1020-1032
1032-1047
1047-1059
1059-1114
1114-1126
1126-1141
1141-1153
1153-1200
1250-1300
Li-Ping Xie, People's Republic of China
1300-1400
Raed Azhar, Saudi Arabia
Simon Tanguay, Canada
Long Wang
1400-1500
Moderators
Peter Black, Canada
Seiji Naito, Japan
1500-1600
Luc Valiquette, Canada
Long Wang
1600-1700
Moderators
Peng Wu
Kevin Zorn, Canada
1300-1310
Saeed R. Samnakay, Kenya
1310-1325
1325-1340
1340-1355
1355-1410
1410-1425
1425-1440
1440-1455
1455-1500
Co-Chairs: Papa Ahmed Fall, Senegal / E.Oluwabunmi Olapade-Olaopa, Nigeria
1500-1510
1510-1520
1520-1530
1530-1540
1540-1550
1550-1600
1600-1615
1615-1625
1625-1650
Emmanuel Abara, Canada
Mohamed Jalloh, Senegal
Aaron D. Martin, United States
1650-1700
Thursday, November 10
Please click on the session titles to view the session details when available.
Friday, November 11
Please click on the session titles to view the session details when available.
Saturday, November 12
Please click on the session titles to view the session details when available.
Sunday, November 13
Please click on the session titles to view the session details when available.
1315-1320
1320-1335
1335-1350
1350-1405
1405-1420
1420-1435
1435-1440
• Biography
• Biography
• Biography
• Biography
Closing Remarks
• Biography
• Biography
• Biography
• Biography
• Biography
• Biography
• Biography
• Biography
Bienvenida
Despedida
Plática 4: Terapia focal de rescate en Cáncer de Próstata
• Biography
• Biography
• Biography
• Biography
• Biography
• Biography
• Biography
• Biography
• Biography
• Biography
• Biography
• Biography
• Biography
• Biography
• Biography
Award distributions for the Best Moderated Poster, Best Un-moderated Poster and Best Video presentations. and Closing SANTU-10 and Invitation to SANTU-11, 2023
Low Cost Innovations which have reached the masses and the Markets: A Critical Appraisal
The “Innovators Talk Show”: Dialogues with the innovators
• Biography
Training in Minimally Invasive Urology in SSA : A Call for Action
• Biography
Framing of Theme
Optimizing Treatment for Locally Advanced Prostate Cancer
SESSION ONE | ADVANCED PROSTATE CANCER
• Biography
• Biography
• Biography
• Biography
• Biography
• Biography
• Biography
• Biography
• Biography
• Biography
Framing of Theme
Introduction
• Biography
• Biography
Low Cost Urology
Opening SANTU
• Biography
• Biography
• Biography
• Biography
• Biography
• Biography
• Biography
• Biography
• Biography
Urethroplasty in Obliterative Urethral Stricture Disease - Transection vs Augmentation
• Biography
Welcome Message
• Biography
• Biography
• Biography
• Biography
• Biography
• Biography
• Biography
• Biography
• Biography
Welcome Message
• Biography
• Biography
SESSION FIVE | PCA LOCALIZED PART 1
• Biography
• Biography
• Biography
• Biography
• Biography
• Biography
Update on Tissue Based Prostate Biomarkers
• Biography
• Biography
• Biography
• Biography
• Biography
Bienvenida
Despedida
• Biography
• Biography
Section Three: Urinary Stones
SWL for Urinary Stones: Past, Present, and Future
• Biography
How to Treat a Prostate > 80 cc Best Surgically
Section Four: BPH
Section Two: Bladder Cancer
• Biography
• Biography
Announcement of the Results and Awards Distribution of 5th Best Affordable New Technologies in Urology contest (BANTUC)
Invitation to 6th Best Affordable New Technologies in Urology Contest (BANTUC)
KISS (Keep It Simple, Stupid) and IP (Idiot Proof) principles when developing frugal devices
Presentation of 5th Best Affordable New Technologies in Urology contest (BANTUC)
• Biography
• Biography
• Biography
• Biography • Disclosure information